Core Scientific (NASDAQ:CORZ) Announces Earnings Results

Core Scientific (NASDAQ:CORZ) issued its quarterly earnings data on Monday. The company reported $0.42 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.27) by $0.69, FiscalAI reports. The firm had revenue of $79.76 million during the quarter, compared to analyst estimates of $118.45 million. The firm’s revenue was down 16.0% compared to the same quarter last year. During the same period last year, the business earned ($0.69) EPS.

Here are the key takeaways from Core Scientific’s conference call:

• Core Scientific emphasized strong execution, stating it has energized ~350 megawatts of capacity with nearly 200 megawatts billing, and will report capacity on a billing basis going forward.
• Management missed its goal to sign a new customer by the call — no new colo contract was executed yet — though two sites are under short exclusivity and management says signing is a timing (not demand) issue.
• The company expanded its development footprint and pipeline, including a planned Hunt County, TX acquisition (~265 acres supporting ~430 MW gross / ~285 MW leasable) expected to close by end of Q1 with ERCOT energization scheduled 2027–2029.
• Balance-sheet and financing optionality look solid with ~$530 million liquidity, opportunistic Bitcoin sales (~1,900 BTC for ~$175 million), and access to a range of financing including up to $4 billion against contracted CoreWeave capacity and project financing at 60–85% advance rates.
• The company disclosed a historical accounting error related to demolition costs after switching auditors, filed amended statements, and noted a material weakness for the next four quarters, though management said there was no impact to revenue, adjusted EBITDA, or net cash flow.

Core Scientific Stock Up 4.2%

NASDAQ:CORZ opened at $15.95 on Wednesday. The business’s 50-day moving average price is $17.27 and its 200 day moving average price is $16.96. Core Scientific has a 52-week low of $6.20 and a 52-week high of $23.63. The firm has a market cap of $4.95 billion, a P/E ratio of 13.63 and a beta of 6.87.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on CORZ shares. Keefe, Bruyette & Woods increased their price target on shares of Core Scientific from $19.00 to $25.00 and gave the stock a “moderate buy” rating in a research report on Tuesday, January 27th. Cantor Fitzgerald reduced their target price on Core Scientific from $26.00 to $25.00 and set an “overweight” rating on the stock in a report on Tuesday. Zacks Research upgraded Core Scientific from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 13th. BTIG Research raised Core Scientific from a “neutral” rating to a “buy” rating and set a $23.00 price target on the stock in a research report on Tuesday, January 6th. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Core Scientific in a report on Wednesday, January 21st. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating, three have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat.com, Core Scientific has an average rating of “Moderate Buy” and an average target price of $24.66.

Institutional Investors Weigh In On Core Scientific

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Value Aligned Research Advisors LLC purchased a new position in shares of Core Scientific in the fourth quarter worth approximately $117,786,000. Situational Awareness LP boosted its stake in Core Scientific by 76.8% in the 2nd quarter. Situational Awareness LP now owns 7,994,038 shares of the company’s stock worth $136,458,000 after purchasing an additional 3,472,460 shares during the period. State Street Corp grew its position in Core Scientific by 3.3% during the 4th quarter. State Street Corp now owns 7,156,301 shares of the company’s stock worth $104,196,000 after purchasing an additional 230,048 shares in the last quarter. Helix Partners Management LP raised its stake in Core Scientific by 6.7% during the 4th quarter. Helix Partners Management LP now owns 5,600,000 shares of the company’s stock valued at $81,536,000 after purchasing an additional 350,000 shares during the period. Finally, JPMorgan Chase & Co. raised its stake in Core Scientific by 584.2% during the 4th quarter. JPMorgan Chase & Co. now owns 3,689,053 shares of the company’s stock valued at $53,713,000 after purchasing an additional 3,149,859 shares during the period.

Trending Headlines about Core Scientific

Here are the key news stories impacting Core Scientific this week:

• Positive Sentiment: Q4 EPS beat and earnings details — CORZ reported $0.42 EPS for Q4 (well above the consensus loss of ($0.27)), reversing prior-year losses and showing material improvement on profitability metrics. This surprise beat has been cited by bulls as evidence the transition is beginning to pay off. Earnings Call Highlights
• Positive Sentiment: Colocation revenue is accelerating — Colocation/AI-support revenue surged (reported ~268% YOY in some coverage), driven by contracts and ramping capacity that investors view as higher-margin, recurring business versus cyclical Bitcoin mining. Colocation Revenue Surge
• Positive Sentiment: CoreWeave deal ahead of schedule — Coverage notes the CoreWeave colocation agreement is progressing faster than expected, supporting the company’s faster-than-expected AI shift and near-term revenue visibility. CoreWeave Deal
• Positive Sentiment: Bullish analyst activity — Multiple firms reiterated or raised buy ratings (Needham upgraded to Buy with a $23 PT; HC Wainwright reaffirmed Buy; others maintained overweight stances), signaling institutional analyst conviction in the AI/colocation transition. Analyst Actions
• Positive Sentiment: Unusually heavy call buying — Options volume spiked (roughly 188,642 calls traded), indicating speculative bullish positioning or hedging by institutional players that can amplify near-term upside moves. (Source: trading activity reports)
• Neutral Sentiment: 1.5 GW expansion push — Management reiterated aggressive capacity expansion (1.5 GW pipeline). This supports long-term revenue growth but increases near-term capex and execution risk. Expansion Article
• Neutral Sentiment: Positive longer-term narrative — MarketBeat and other commentators highlight a multi-year AI opportunity (large contracted revenue backlog cited), which supports a bullish longer-term thesis but is execution-dependent. MarketBeat AI Thesis
• Neutral Sentiment: Short-interest data appears unreliable — Recent short-interest reports show zeros/NaN in some feeds (likely a data glitch), so don’t read too much into short-covering narratives until figures are clarified.
• Negative Sentiment: Revenue miss and top-line pressure — Q4 revenue of ~$79.8M missed consensus (~$118M) and was down ~16% YoY, a clear headwind and the main reason some investors are selling despite the EPS beat. Press Release / Slide Deck
• Negative Sentiment: Market reaction and volatility — Some coverage reports sharp share declines (including a ~14% intraday drop in some headlines) after the company emphasized the pivot to AI/colocation and flagged swingy results — investors are worried about near-term cash flow and execution. Price Reaction Article
• Negative Sentiment: Profitability and balance-sheet risks — Coverage notes negative adjusted EBITDA tied to rapid expansion and a larger shareholder deficit in 2025, raising short-term funding and margin concerns until colocation ramps and BTC asset monetization proceed. Zacks Q4 Analysis

About Core Scientific

Core Scientific, Inc (NASDAQ: CORZ) is a leading provider of large-scale blockchain infrastructure and digital asset mining services. The company develops, owns and operates high-performance data centers optimized for the mining of Bitcoin and other proof-of-work cryptocurrencies. In addition to its core mining operations, Core Scientific offers colocation, hosting and managed services designed to support institutional clients and enterprise users in deploying and scaling blockchain nodes and computing hardware.

Core Scientific’s service portfolio includes hardware procurement, deployment and maintenance, real-time monitoring, power management and network connectivity.